Popular Articles

Mayo Clinic Study Finds Earliest Evidence Of Memory Decline In Middle-Aged People At Genetic Risk For Alzheimer's Disease
Memory lapses that occur with normal aging are a of worry for many who fear Alzheimer"s disease. Now a new Mayo Clinic-led study published in the July 16 issue of the New England Journal of Medicine suggests that the carriers of a common genetic risk factor for Alzheimer"s disease begin to have memory declines in their mid-50s, far earlier than previously thought.

HSE Warns Employers About The Safety Of Equipment After Worker's Hand Is Damaged By Rotating Blades, UK
The Health and Safety Executive (HSE) is warning employers to ensure they assess the safety of equipment and ensure that it is sufficiently guarded after an employee"s left hand was severely damaged by the rotating blades of a valve that forms part of the extraction system in a metal recycling process.
News of the day
Doctors And Software Engineers Pioneer An Advanced Sepsis Detection And Management System
When Jason Martin gives a talk about his research, he begins with the dramatic story of Mariana Bridi da Costa: The young Brazilian supermodel died from severe sepsis in January after amputation of both her hands and feet failed to stop its spread.
Mental Health

Experts Disagree On Whether Healthy People Should Take Brain Boosting Drugs

It is unethical to stop healthy people from taking methylphenidate (Ritalin) to enhance their mental performance, says John Harris, Professor of Bioethics at the University of Manchester, in an article published on bmj.com today. He adds that society "ought to want [enhancement]" and that "it is not rational to be against human enhancement." In total disagreement, Professor Anjan Chatterjee from the University of Pennsylvania argues that there are too many risks in taking Ritalin unless you are actually ill. He notes that the Food and Drug Administration labelled it with a "black box" the most alarming of possible warnings. This is because there is a high potential for abuse, dependence, risk of sudden death and serious adverse effects on the heart, he says. Chatterjee adds that there are cognitive trade-offs by taking Ritalin, for example a loss in creativity. He points out that "being smarter does not mean being wiser" and cites the very smart people who developed ways to distribute financial risk which in turn contributed to the current global economic crisis. Professor Chatterjee is also concerned about the end-goal of taking drugs to enhance cognitive abilities. He not only fears that children at top preparatory schools will end up taking Ritalin in "epidemic proportions" but asks whether pilots, the police and doctors on-call be pressurised into taking these drugs? In conclusion, Chatterjee does not believe it is acceptable to recommend that healthy people take Ritalin to enhance performance until proper safeguards are in place. Professor Harris, on the other hand, believes that these arguments are not persuasive. Harris on the contrary emphasises personal liberty and public safety. As no drug is side effect free, Harris believes Ritalin is "safe enough" given that children and young people with attention deficit hyperactivity disorder are routinely treated for long periods with it. Professor Harris adds that "humans are creatures that result from an enhancement process called evolution and moreover are inveterate self-improvers in every conceivable way." Harris argues that change or progress often carries risk. The development of "synthetic sunshine" (firelights, lamplight and electric light), for example, could have forced people to work through the night. However, the answer was not to outlaw synthetic sunshine but to introduce laws to regulate working hours. "The same is or will be true of chemical cognitive enhancers," he says. British Medical Journal


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):